These excerpts taken from the SNTA 10-K filed Mar 26, 2009.
1.35. Indication means any human disease or condition, or sign or symptom of a human disease or condition.
1.36. Initiation means, with respect to a Clinical Trial, the first dosing of the first patient enrolled in such Clinical Trial with a Licensed Product; and with respect to a GLP Toxicology Study, the first dosing of the first mammal in such study.
1.35. Indication means any human